Suppliers / Zhejiang Huafang Pharmaceutical

Zhejiang Huafang Pharmaceutical

China 1 employees Updated 9 July 2026

Zhejiang Huafang Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Cefcapene US FDA 1
Cefditoren US FDA 1

Also appears on these molecule pages

Cefditoren API

Questions about Zhejiang Huafang Pharmaceutical

Does Zhejiang Huafang Pharmaceutical hold a US DMF or a CEP?
Zhejiang Huafang Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Zhejiang Huafang Pharmaceutical make?
2 molecules are on record against Zhejiang Huafang Pharmaceutical, including Cefcapene and Cefditoren. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Huafang Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Orchid Pharma shares 1 molecule Aktin Pharmaceuticals also in China Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division) also in China Anhui Wanhe Pharmaceutical also in China Anhui Worldbest Pharmaceutical also in China

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability